REWARDS- In-stent Restenosis

Withdrawn before enrolling

Conditions studied: In-Stent Coronary Artery Restenosis

In brief

To define the long-term incidence and frequency of ISR follow DES implantation. Compare the clinical presentation, treatment and intervention success among de novo coronary artery stenosis and DES ISR. Compare short- and long-term outcomes of de novo coronary artery stenosis and DES ISR, assessed by incidence of mortality, MACE, MI, and TLR/TVR at index hospitalization, 30 days, 6 months, 1 year, 3 years, and 5 years, if available.

Key facts

Study ID

NCT03008772

Run by

Medstar Health Research Institute

People needed

0

Starts

2018-02-01

Expected to finish

2024-01-01

Last updated by the study team

2020-10-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients, male or female, > 18 years of age,
• Patients who received at least one (1) commercially available Drug Eluting Stent

You may not qualify if…

• none

Where it is running

• MedStar Washington Hospital Center — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.